IP Library › Assignment 035557/0644
Patent Assignment
Reel/Frame 035557/0644

Organization Conversion

Recorded: 2015-04-30 Pages: 4
Assignor
VAXIION THERAPEUTICS, INC.
Executed: 2014-01-24
Assignee
VAXIION THERAPEUTICS, LLC
11585 SORRENTO VALLEY RD, SUITE 105, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (14)
Regulated Genetic Suicide Mechanism Compositions and Methods
Therapeutic Compositions and Methods for Antibody and Fc-Containing Targeting Molecule-Based Targeted Delivery of Bioactive Molecules by Bacterial Minicells
Immunomodulatory Minicells and Methods of Use
Eubacterial Minicells and Their Use as Vectors for Nucleic Acid Delivery and Expression.
Patent: 7,183,105 →
Application: 10/156,902 →
Publication: US 2003/0199088
Immunogenic Minicells and Methods of Use
Patent: 7,396,822 →
Application: 10/832,000 →
Publication: US 2005/0147590
Rhamnose-Inducible Expression Constructs and Methods
Patent: 7,871,815 →
Application: 11/580,095 →
Publication: US 2007/0122881
Minicells Displaying Antibodies or Derivatives Thereof and Comprising Biologically Active Compounds
Patent: 8,101,396 →
Application: 11/725,196 →
Publication: US 2011/0281330
Immunogenic Minicells and Methods of Use
Patent: 8,129,166 →
Application: 12/133,308 →
Publication: US 2009/0011490
Therapeutic Compositions and Methods for Antibody and Fc-Containing Targeting Molecule-Based Targeted Delivery of Bioactive Molecules by Bacterial Minicells
Application: 13/397,313 →
Publication: US 2012/0207754
Immunogenic Minicells and Methods of Use
Patent: 8,524,484 →
Application: 13/412,559 →
Publication: US 2012/0252099
Regulated Genetic Suicide Mechanism Compositions and Methods
Patent: 9,045,761 →
Application: 13/711,482 →
Publication: US 2013/0210121
Minicell Based Delivery of Biologically Active Compounds
Patent: 9,017,986 →
Application: 13/957,372 →
Publication: US 2013/0337545
Immunomodulatory Minicells and Methods of Use
Patent: 9,267,108 →
Application: 14/044,525 →
Publication: US 2014/0093954
Minicell Based Delivery of Biologically Active Compounds
Patent: 9,670,270 →
Application: 14/693,338 →
Publication: US 2015/0218254
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 18, 2002
From: SABBADINI, ROGER A.; BERKLEY, NEIL; SURBER, MARK W.
To: MPEX BIOSCIENCES, INC.
Reel/Frame 013287/0387 →
Assignment of Assignor's Interest Aug 19, 2004
From: SABBADINI, ROGER A.; BERKLEY, NEIL
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 015075/0397 →
Change of Name Dec 6, 2004
From: MPEX BIOSCIENCE INC.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 015429/0413 →
Change of Name May 18, 2006
From: MPEX PHARMACEUTICALS, INC.
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 017647/0201 →
Assignment of Assignor's Interest Feb 25, 2008
From: SURBER, MARK
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 020559/0568 →
Assignment of Assignor's Interest Mar 17, 2011
From: KLEPPER, ROBERT
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 025996/0399 →
Assignment of Assignor's Interest Feb 17, 2012
From: GIACALONE, MATTHEW J
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 027726/0059 →
Assignment of Assignor's Interest Apr 13, 2012
From: GIACALONE, MATTHEW J; NEWMAN, MICHAEL J
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 028046/0447 →
Security Agreement Mar 21, 2013
From: VAXIION THERAPEUTICS INC.
To: WESTERN STATES INVESTMENT COMPANY, LLC
Reel/Frame 030062/0774 →
Assignment of Assignor's Interest Nov 25, 2013
From: GIACALONE, MATTHEW J.
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 031673/0221 →
Assignment of Assignor's Interest Feb 21, 2019
From: GIACALONE, MATTHEW J.; NEWMAN, MICHAEL J.
To: VAXIION THERAPEUTICS, INC.
Reel/Frame 048402/0607 →
Assignment of Assignor's Interest Mar 1, 2019
From: GIACALONE, MATTHEW J.
To: VAXIION THERAPEUTICS, LLC
Reel/Frame 048473/0587 →